GE HealthCare reports second quarter 2026 financial results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
GE HealthCare (GEHC) Tops Q2 EPS by 9c, Beats on Revenue; Reaffirms Guidance
July 29, 2026 6:22 AM EDTGE HealthCare (NASDAQ: GEHC) reported Q2 EPS of $1.13, $0.09 better than the analyst estimate of $1.04. Revenue for the quarter came in at $5.3 billion versus the consensus estimate of $5.26 billion.
The company reaffirmed its full-year 2026 guidance.
For earnings history and earnings-related data on GE HealthCare (GEHC) click here.
... More